RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Viamet Pharmaceuticals, Inc., a pharmaceutical company developing novel, best in class metalloenzyme inhibitors, announced today that William Moore, Ph.D. has joined the company as Chief Scientific Officer.
